Position in CDXS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$59,116
+$15,190 QoQ
Shares Held
26,158
-2.9% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 148 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GUGGENHEIM CAPITAL LLC holds $211,944,812 across 76 Biotechnology names. CDXS ranks #72 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
115,233 | $57,239,687 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
45,969 | $28,663,508 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
39,318 | $11,835,897 | |
| 4 | INCY |
Incyte Corp
|
57,780 | $6,549,940 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26,474 | $4,958,050 | |
| 6 | INSM |
INSMED Inc
|
38,766 | $4,133,230 | |
| 7 | MRNA |
Moderna, Inc.
|
55,313 | $3,873,568 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
66,874 | $3,826,530 |
All Filings in CDXS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,116 | 26,158 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $43,926 | 26,950 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,586 | 27,355 | Shares | Defined | 2026-02-17 | |
| 2021-06-30 | $409,171 | 18,057 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $488,701 | 21,350 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $472,968 | 21,666 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $259,125 | 22,072 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $258,609 | 22,685 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $260,039 | 23,301 | Shares | Defined | 2020-06-02 | |
| No filing history on record for this holder in this stock. | ||||||